Pr Frédéric Batteux, from University Paris Descartes, France published in January 2014 a paper in the Journal of Clinical Investigation on the role of an original SOD mimic, mangafodipir, on oxaliplatin-induced peripheral neuropathy. The result of this paper is original as it combines both basic research and a clinical trial and open a new therapeutic opportunity for treatment of chemotherapy induced neuropathy.
Pr Batteux will highlight these results during ISANH Antioxidants World Congress 2014, which will be held in Paris on June 12-13. If you are interested to know more about this strategic topic, come and join Antioxidants World Congress.
For more information: www.isanh.fr